Conference Presentation Details - Overview
Clinical Conundrums in Lymphoma: Management of Aggressive Lymphomas
Release Date: December 22, 2009|
Expiration Date: December 22, 2010
2.25 AMA PRA Category 1 Credit(s)™|
Dec 4, 2009, New Orleans, LA
At the conclusion of this educational activity, you should be able to:
- Discuss current treatment options for patients with aggressive lymphoma, including mantle cell lymphoma, T-cell lymphoma, transformed lymphoma, and diffuse large B-cell lymphoma, in both first-line and relapsed/refractory settings
- Describe emerging treatment strategies for patients with mantle cell lymphoma, T-cell lymphoma, transformed lymphoma, and diffuse large B-cell lymphoma
- Apply data from clinical trials to determine the optimal course of therapy in defined patient populations
Overview and Purpose
The purpose of the Clinical Conundrums in Lymphoma: Management of Aggressive Lymphomas satellite symposium is to provide practicing community oncologists and hematologists with a practical overview of the optimal management of clinically challenging aggressive lymphomas. The format of this program is designed to assess the practical applicability of evolving strategies and clinical trial findings in aggressive lymphomas using case-based discussions. Efficacy and safety information will be integrated into a patient management activity structured around the presentation of challenging cases in each malignancy. Experts will discuss each case in the context of available data, with the goal of defining an optimal treatment plan for each patient subtype. This unique and dynamic program design seeks to improve patient care by facilitating the immediate integration of current data into improved treatment options for routine and difficult clinical scenarios in each disease setting.
This educational program is directed toward medical oncologists and hematologists interested in the treatment of patients with hematologic malignancies. Fellows, nurses, and pharmacists interested in the treatment of hematologic malignancies are also invited to participate.
Choose a Participation Option
To claim credit for this activity you must:
- Take the Pretest
- Participate in the Activity
- Take the Posttest
- Take the Evaluation
- Claim your Credit Amount & Certificate Type
If you do not wish to claim credit:
You may bypass all CE information, tests and evaluations and go straight to the activity.
You may not request credit after viewing the activity.
I wish to participate in this
activity and claim credit.
I wish to view the activity
without claiming credit.